The financing round was led by Glenview Capital and co-led by Novo Holdings.
"Everybody knows that dialysis care must improve. For this to happen, providers and physicians need products that allow greater flexibility to bring dialysis directly to the patient, while simplifying complexity and reducing the overall cost of care. Our small, simple-to-use, and powerful dialysis system SC+ is positioned to help transform kidney care. The funding we are announcing today will allow us to accelerate our emergence as a significant force in this market."
The oversubscribed round was co-led by BlackRock and Canada Pension Plan Investment Board with backing from existing investors.
"This funding round represents another significant milestone in our journey to become the operating system of choice for leading banks across the globe,"
The financing round was co-led by Accel and Tiger Global to support the company's global expansion.
"This latest investment allows us to accelerate our growth at every level – doubling down on our successful product led growth strategy, adding to our customer roster, recruiting talent to our team worldwide and expanding geographically."
